Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SHE:002940)

China · Delayed Price · Currency is CNY

24.35

-0.85 (-3.37%)

Sep 10, 2026, 12:44 PM CST

Market Cap	4.94B -40.4%
Revenue (ttm)	1.33B -6.2%
Net Income	114.44M +46.4%
EPS	0.56 +43.9%
Shares Out	196.11M
PE Ratio	44.95
Forward PE	n/a
Dividend	0.30 (1.18%)
Ex-Dividend Date	Jun 22, 2026

Volume	5,645,800
Open	25.71
Previous Close	25.20
Day's Range	24.07 - 25.71
52-Week Range	23.11 - 48.90
Beta	0.71
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 25, 2026

About SHE:002940

Zhejiang AngLiKang Pharmaceutical CO.,LTD. engages in the research, development, production, and sale of pharmaceuticals in China and internationally. The company offers chemical raw materials for pharmaceuticals comprising oral cephalosporin antibiotic raw materials, including cephalexin, cefadroxil, cefaclor, and cefadroxil; alpha-keto acid raw materials; inhaled anesthetic raw materials, such as isoflurane and sevoflurane; and anti-androgen intermediates, including finasteride and dutasteride. It also provides chemical agents consisting of a... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2001

Employees 1,236

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 002940

Full Company Profile

Financial Performance

In 2025, SHE:002940's revenue was 1.42 billion, a decrease of -7.35% compared to the previous year's 1.54 billion. Earnings were 125.44 million, an increase of 56.15%.

Financial Statements